Literature DB >> 11641586

Long-term follow-up of patients after intraarterial thrombolytic therapy of acute vertebrobasilar artery occlusion.

U Sliwka1, M Mull, A Stelzer, R Diehl, J Noth.   

Abstract

Local thrombolysis may reduce mortality after acute vertebrobasilar artery occlusion. We focused on variables affecting recanalization, outcome and long-term prognosis. Thirty-six patients with vertebrobasilar artery occlusion were treated with local intraarterial thrombolytic therapy. Four of the survivors were among the 16 patients without recanalization. Recanalization was associated with a higher survival rate. Top-of-the-basilar-type occlusions have the highest recanalization rate. The thrombolytic medication used did not influence the recanalization frequency. One patient died due to an intracerebral bleed after thrombolysis. There was no association between the time interval (greater or less than 6 h) between the onset of symptoms and therapy initiation and survival. Relapses during follow-up (mean follow-up 3.7 years) did not occur. MRI/MRA and ultrasound studies during follow-up showed unchanged results in these patients. All survivors at the time of follow-up lived at home. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11641586     DOI: 10.1159/000047706

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  12 in total

1.  Local intra-arterial fibrinolysis in acute basilar artery occlusion.

Authors:  Y Enomoto; S Yoshimura; H Kitajima; N Tamakawa; T Iwama
Journal:  Interv Neuroradiol       Date:  2007-06-27       Impact factor: 1.610

Review 2.  Basilar artery occlusion.

Authors:  Tracey A Baird; Keith W Muir; Ian Bone
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

3.  Review of pharmacology and physiology in thrombolysis interventions.

Authors:  M Grace Knuttinen; Neelmini Emmanuel; Furquaan Isa; Alex W Rogers; Ron C Gaba; James T Bui; Charles A Owens
Journal:  Semin Intervent Radiol       Date:  2010-12       Impact factor: 1.513

4.  Brain stem diffusion-weighted imaging lesion score: a potential marker of outcome in acute basilar artery occlusion.

Authors:  T-H Cho; N Nighoghossian; F Tahon; C Némoz; M Hermier; F Salkine; L Derex; P Trouillas; J-C Froment; F Turjman
Journal:  AJNR Am J Neuroradiol       Date:  2008-09-03       Impact factor: 3.825

5.  [Interventional endovascular therapy (stenting) for residual stenosis after lysis of the basilar artery].

Authors:  S Boy; K Isenhardt; K Gardill; B Kapp; R Schneider; J Berkefeld
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

6.  Endovascular management in patients with acute basilar artery obstruction: low-dose intra-arterial urokinase and mechanical clot disruption.

Authors:  J S Yun; Hyo Sung Kwak; S B Hwang; G H Chung
Journal:  Interv Neuroradiol       Date:  2011-12-16       Impact factor: 1.610

7.  Outcome in patients with basilar artery occlusion treated conventionally.

Authors:  W J Schonewille; A Algra; J Serena; C A Molina; L J Kappelle
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

8.  Vertebrobasilar artery occlusion.

Authors:  Jessica C Schoen; Megan M Boysen; Chase R Warren; Bharath Chakravarthy; Shahram Lotfipour
Journal:  West J Emerg Med       Date:  2011-05

9.  Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis.

Authors:  M Arnold; K Nedeltchev; G Schroth; R W Baumgartner; L Remonda; T J Loher; F Stepper; M Sturzenegger; B Schuknecht; H P Mattle
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

10.  Vertebral artery dissection complicated by basilar artery occlusion successfully treated with intra-arterial thrombolysis: three case reports.

Authors:  Paolo Cerrato; Maurizio Berardino; Edo Bottacchi; Giovanni Corso; Alessandra Lentini; Giovanni Bosco; Eleonora Destefanis; Mariagiovanna Caprioli; Dino Daniele; Gianni Boris Bradac; Mauro Bergui
Journal:  Neurol Sci       Date:  2008-04-01       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.